News

More people may be at risk for developing COPD due to exposure to environmental irritants, such as heat waves and air ...
Increased perceived stress may cause worsened respiratory symptoms and decreased quality of life in people with chronic obstructive pulmonary disease (COPD), according to a new study.
Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...
Increased perceived stress may cause worsened respiratory symptoms and decreased quality of life in people with chronic obstructive pulmonary disease (COPD), according to a new study.
Medicaid beneficiaries face higher rates of pulmonary hypertension, with significant economic burdens and racial disparities in prevalence and costs.
Mansfield and Ashfield Chad on MSN1d
New programme to launch to support COPD patients
Nottinghamshire Healthcare’s community respiratory nurses are excited to pilot a brand new programme for patients with newly ...
Leading specialists in pulmonology have formed Healio Pulmonology’s Peer Perspective Board to help guide coverage and provide ...
Advanced Treatments Create New Prospects for Patients and Their Healthcare Providers New FDA-approved medical treatments can be transformative for patients and families, often providing them with more ...
For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical ...
This is part two of a two-part Healio Exclusive series on nutrition and lung health. Part one can be viewed here. Diet is an ...
Advances in biomarker development are also shaping the future of COPD care. Currently available biomarkers often lack specificity, making it difficult to differentiate between stable and acute disease ...